Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Grace Therapeutics, Inc.

NASDAQ: GRCE · Life Sciences · 9 alerts · CIK 1444192

Share price
$1.75Close, Nov 16
Market cap
$36.8M
Shares outstanding
21.04MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Grace Therapeutics, Inc. filings on SEC EDGAR ↗

9:06 PM ET Form 4
Insider Buying

Grace Therapeutics Insider Opaleye Management Inc. Buys $18.5K of Stock

Opaleye Management Inc. bought 10,328 shares of Grace Therapeutics, Inc. at $1.79 a share, worth $18.5K in total on Nov 3, 2026. Shares held after the trade: 3,046,739 (+0.3%).

Value
$18.5K
Shares
10,328
Price
$1.79
Holding change
+0.3%
Trade date
Nov 3, 2026
6:06 PM ET Form 4
Insider Buying

Grace Therapeutics Insider Opaleye Management Inc. Buys $159K of Stock

Opaleye Management Inc. bought 87,801 shares of Grace Therapeutics, Inc. at $1.77 to $1.93 a share (average $1.81) in 2 transactions, worth $159K in total between Oct 22, 2026 and Oct 26, 2026. Shares held after the trade: 3,036,411 (+2.2%).

Value
$159K
Shares
87,801
Average price
$1.81
Holding change
+2.2%
Trade date
Oct 22, 2026 to Oct 26, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.